Effects of a single dose of orally administered gabapentin in dogs during a veterinary visit: a double-blinded, placebo-controlled study

Ori O. Stollar Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN

Search for other papers by Ori O. Stollar in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
George E. Moore Department of Veterinary Administration, College of Veterinary Medicine, Purdue University, West Lafayette, IN

Search for other papers by George E. Moore in
Current site
Google Scholar
PubMed
Close
 DVM, DACVPM, DACVIM, PhD
,
Abhijit Mukhopadhyay Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN

Search for other papers by Abhijit Mukhopadhyay in
Current site
Google Scholar
PubMed
Close
 PhD
,
Wilson Gwin Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN

Search for other papers by Wilson Gwin in
Current site
Google Scholar
PubMed
Close
 BS Pharmacy
, and
Niwako Ogata Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN

Search for other papers by Niwako Ogata in
Current site
Google Scholar
PubMed
Close
 DVM, PhD, DACVB

Abstract

OBJECTIVE

To evaluate the effects of a single dose of orally administered gabapentin in alleviating stress at a veterinary visit in privately owned dogs.

Animals

22 healthy client-owned dogs (1.5 to 8.5 years old) were enrolled in this study.

PROCEDURES

Each dog received a 50-mg/kg oral dose of either gabapentin or placebo 2 hours before the beginning of each visit protocol. The dog’s behavioral responses were coded from recorded video clips during a 5-minute-long standardized physical examination and pre– and post–physical examination phases. The veterinary technician separately rated each greeting behavior at each visit. Physiological variables during veterinary visits (ie, eye surface temperature and salivary cortisol concentrations) were also compared between the pre– and post–physical examination phases. The owner was queried 24 hours after a visit to determine the incidence of adverse events.

RESULTS

The greeting test score, eye surface temperature, and cortisol concentrations did not differ substantially between the gabapentin and placebo treatment groups. Lip licking frequency during the physical examination phase was significantly lower in the gabapentin treatment group than in the placebo group (P = 0.001). Lip licking frequency during the pre– and post–physical examination phases was also significantly lower in the gabapentin treatment group than in the placebo treatment group (P = 0.004). No serious adverse events were reported by the owners following gabapentin treatment.

CLINICAL RELEVANCE

Results showed that the 50-mg/kg dose of gabapentin was well tolerated without serious adverse effects in healthy dogs. Further studies are recommended of dogs with documented stress in response to a veterinary visit.

Abstract

OBJECTIVE

To evaluate the effects of a single dose of orally administered gabapentin in alleviating stress at a veterinary visit in privately owned dogs.

Animals

22 healthy client-owned dogs (1.5 to 8.5 years old) were enrolled in this study.

PROCEDURES

Each dog received a 50-mg/kg oral dose of either gabapentin or placebo 2 hours before the beginning of each visit protocol. The dog’s behavioral responses were coded from recorded video clips during a 5-minute-long standardized physical examination and pre– and post–physical examination phases. The veterinary technician separately rated each greeting behavior at each visit. Physiological variables during veterinary visits (ie, eye surface temperature and salivary cortisol concentrations) were also compared between the pre– and post–physical examination phases. The owner was queried 24 hours after a visit to determine the incidence of adverse events.

RESULTS

The greeting test score, eye surface temperature, and cortisol concentrations did not differ substantially between the gabapentin and placebo treatment groups. Lip licking frequency during the physical examination phase was significantly lower in the gabapentin treatment group than in the placebo group (P = 0.001). Lip licking frequency during the pre– and post–physical examination phases was also significantly lower in the gabapentin treatment group than in the placebo treatment group (P = 0.004). No serious adverse events were reported by the owners following gabapentin treatment.

CLINICAL RELEVANCE

Results showed that the 50-mg/kg dose of gabapentin was well tolerated without serious adverse effects in healthy dogs. Further studies are recommended of dogs with documented stress in response to a veterinary visit.

All Time Past Year Past 30 Days
Abstract Views 4801 0 0
Full Text Views 8507 5662 441
PDF Downloads 6442 3440 270
Advertisement